5/20/2025CDE Solicits Feedback on Draft Guidelines for Writing Elderly Patient ...

5/20/2025CDE Seeks Comments on Draft Guideline for Age-Friendly Design in Innov...

5/20/2025CDE Solicits Comments on the 94th Batch of Reference Formulations for ...

5/16/2025NMPA Orders Package Insert/Label Update for Ranitidine Injection Amid ...

5/14/2025CDE Issues the List of Reference Formulations for GQCE Studies (92nd B...

5/14/2025Six Drugs Granted Priority Review as China Registers Over 1,100 Produc...

5/7/2025CDE Seeks Comments on Draft Guidelines for Subject Selection in Bioequ...

5/7/2025CDE Publicizes the List of Reference Formulations for Generic Chemical...

5/6/2025China Seeks Feedbacks on Draft Guideline for Risk Management Plan Duri...

5/6/2025China Seeks Feedbacks on ICH Q1 Stability Testing Guideline Draft

5/6/2025China Announces Ambitious Plan to Optimize Primary Healthcare System b...

4/29/2025China NMPA Suspends Digoxin API Imports from VITAL LABS

4/22/2025China Seeks Feedback on ICH Draft Guideline M13B for Biowaivers of Add...

4/22/2025CDE Issues the List of Reference Formulations for GQCE Studies (91st B...

4/19/2025China Issues New Guidelines to Streamline Mainland Registration for Or...

4/10/2025China Revises Military Drug Administration Measures to Strengthen Over...

4/8/2025CDE Solicits Comments on Draft Q&A for CMC Issues in rAAV-Based In Vi...

4/7/2025China Receives 2.6 Million ADR Reports in 2024, Severe Cases Make Up 1...

4/7/2025NMPA Mandates Digital QR Code System for Drug Manufacturing Licenses

4/7/2025NMPA Solicits Comments on the Announcement on Matters Related to the I...

4/5/2025China and WHO Collaborate on Quality Management Training to Boost Vacc...

3/31/2025CDE Solicits Comments on the Draft Technical Specification of ICH M11:...

3/26/2025NMPA Issues Announcement on the Implementation of Chinese Pharmacopoei...

3/26/2025NMPA Holds 2025 National Drug Regulatory Policy and Law Conference

3/24/2025CDE Seeks Public Comments on Draft ICH M11 Clinical Protocol Template

3/21/2025CDE Solicits Comments on Chinese Translation of ICH E6 (R3) GCP Guidel...

3/20/2025State Council Issues the Opinion on Enhancing TCM Quality and Promotin...

3/20/2025CDE Publicizes the List of Reference Formulations for GQCE Studies (92...

3/20/2025NMPA Seeks Public Feedback on Draft Guidelines for Drug Trial Data Pro...

3/19/2025CDE Issues the 2024 Annual Drug Evaluation Report with Record Surge in...

Page:2/7 Total number of articles:199: [First][<<] [1] [2] [3] [4] [5] [>>] [End]